A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis

Fertility and Sterility

Volumn 90, Issue 1, 2008, Pages 183-184

  Fedele, Luigi ^a   Bianchi, Stefano ^a   Montefusco, Sarah ^a   Frontino, Giada ^a   Carmignani, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BLADDER BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTOSCOPY; DRUG EFFECT; ENDOMETRIOSIS; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; MEDICAL INFORMATION; PILL; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOMATOLOGY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

CONTRACEPTIVES, ORAL; ENDOMETRIOSIS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER DISEASES;

EID: 45849118711     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.09.060     Document Type: Article

References (2)

1. Vercellini P., Frontino G., De Giorgi O., Pietropaolo G., Pasin R., and Crosignani P.G. Continuous use of oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 80 (2003) 560-563
2. Seracchioli R., Mannini D., Colombo F.M., Vianello F., Reggiani A., and Venturoli S. Cystoscopy-assisted laparoscopic resection of extramucosal bladder endometriosis. J Endourol 16 (2002) 663-666